Research aarkstoreenterprise viral partnering terms and agreements


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Research aarkstoreenterprise viral partnering terms and agreements

  1. 1. ResearchAarkstoreEnterprise Viral Partnering Terms andAgreementsThe Viral Partnering Terms and Agreements report provides comprehensive understanding andunprecedented access to the viral partnering deals and agreements entered into by the worldsleading healthcare companies.Trends in viral partnering dealsAverage deal terms for headline, upfront and royalty by stage of developmentViral partnering agreement structureViral partnering contract documentsTop viral deals by valueMost active viral dealmakersDescriptionThe Viral Partnering Terms and Agreements report provides comprehensive understanding andunprecedented access to the viral partnering deals and agreements entered into by the worldsleading healthcare companies.The report provides a detailed understanding and analysis of how and why companies enterviral partnering deals. The majority of deals are discovery or development stage whereby thelicensee obtains a right or an option right to license the licensors viral technology. These dealstend to be multicomponent, starting with collaborative R&D, and commercialization ofoutcomes.Understanding the flexibility of a prospective partner?s negotiated deals terms provides criticalinsight into the negotiation process in terms of what you can expect to achieve during thenegotiation of terms. Whilst many smaller companies will be seeking details of the paymentsclauses, the devil is in the detail in terms of how payments are triggered ? contract documentsprovide this insight where press releases do not.This report contains over 1,500 links to online copies of actual viral deals and contractdocuments as submitted to the Securities Exchange Commission by companies and theirpartners. Contract documents provide the answers to numerous questions about a prospective
  2. 2. partner?s flexibility on a wide range of important issues, many of which will have a significant impact on each party?s ability to derive value from the deal. The initial chapters of this report provide an orientation of viral dealmaking and business activities. Chapter 1 provides an introduction to the report. Chapter 2 provides an overview of the trends in viral dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development. For more information please visit link: Neel Aarkstore Enterprise Phone:08149852585 Partnering Terms & AgreementsCompanion Diagnostics Partnering Terms & AgreementsBioinformatics Partnering Terms & AgreementsPersonalized Medicine Partnering Terms and AgreementsPersonalized Medicine Partnering Terms and AgreementsDermatology Partnering Terms and AgreementsCardiovascular Partnering Terms and AgreementsObstretics Partnering 2007-2012
  3. 3. Musculoskeletal Partnering AgreementsOncology Partnering Terms and AgreementsPediatrics Partnering Terms and AgreementsMetabolic Partnering Terms and AgreementsImmunology Partnering Terms and AgreementsGenitourinary Partnering Terms and AgreementsGastrointestinal Partnering Terms and AgreementsDental Partnering Terms and AgreementsCentral Nervous System Partnering Terms and AgreementsSexual Health Partnering Terms and AgreementsMucositis Partnering 2007-2012Oral Health Partnering 2007-2012AIDS Partnering 2007-2012Allergy Partnering 2007-2012Systemic Lupus Partnering 2007-2012Inflammatory Partnering 2007-2012Gynecology Partnering Terms and AgreementsRespiratory Partnering Terms and AgreementsBacterial Partnering Terms and AgreementsViral Partnering Terms and AgreementsAnthrax Partnering 2007-2012E.coli Partnering 2007-2012MRSA Partnering 2007-2012Sepsis Partnering 2007-2012Common Cold Partnering 2007-2012Hepatitis Partnering 2007-2012Herper simplex Partnering 2007-2012HIV Partnering 2007-2012Influenza Partnering 2007-2012RSV Partnering 2007-2012Parasitic Partnering 2007-2012Fungal Partnering 2007-2012Tropical Disease Partnering 2007-2012
  4. 4. Dengue Fever Partnering 2007-2012Malaria Partnering 2007-2012Renal Failure Partnering 2007-2012Dialysis Partnering 2007-2012Genitourinary Symptoms Partnering 2007-2012Chronic Kidney Disease Partnering 2007-2012Blood Substitute Partnering 2007-2012Anemia Partnering 2007-2012Hemophilia Partnering 2007-2012